Positron-emission tomographic imaging of cancer: Glucose metabolism and beyond

被引：38

作者：

Mankoff, DA

Bellon, JR

机构：

[1] Univ Washington, Med Ctr, Div Nucl Med, Seattle, WA 98195 USA

[2] Univ Washington, Dept Radiat Oncol, Seattle, WA 98195 USA

来源：

SEMINARS IN RADIATION ONCOLOGY | 2001年 / 11卷 / 01期

关键词：

D O I：

10.1053/srao.2001.18100

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Positron emission tomography (PET) has become an important diagnostic tool in oncology. We briefly review the physics of PET, instrumentation for imaging, and approaches to radiopharmaceutical production. The principles underlying the use of [18F]-fluorodeoxyglucose (FDG) are described, and the clinical experience with FDG pertinent to radiation oncology is reviewed. Finally, preliminary studies using PET tracers with greater specificity than FDG for tumor imaging are discussed. Emphasis is placed on underlying principles and those aspects of oncologic PET most applicable to radiation oncology. © 2001 by W.B. Saunders Company.

引用

页码：16 / 27

页数：12

共 102 条

[1] Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer [J].